This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on well-being). The goal of this study is to collect information about financial costs patients may have as a result of surgical treatment for cancer with or without breast reconstruction and to learn if COVID-19 affects patient costs of breast reconstruction. This may help researchers demonstrate the financial consequences of undergoing breast surgery.
Have an indication for surgical treatment of invasive breast cancer or ductal breast carcinoma in situ (DCIS) or prophylaxis in the setting of genetic mutations or strong family history
English-speaking
Able to complete consent
Able to fill out computer survey material
Non-English-speaking
Those with recurrent or metastatic disease or concurrent primary cancers
Patients undergoing breast conservation therapy will also be excluded from the study
M.D. Anderson Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator